WO2007031329A3 - Use of a collagen of xenogeneic origin - Google Patents
Use of a collagen of xenogeneic origin Download PDFInfo
- Publication number
- WO2007031329A3 WO2007031329A3 PCT/EP2006/009004 EP2006009004W WO2007031329A3 WO 2007031329 A3 WO2007031329 A3 WO 2007031329A3 EP 2006009004 W EP2006009004 W EP 2006009004W WO 2007031329 A3 WO2007031329 A3 WO 2007031329A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- collagen
- xenogeneic origin
- xenogeneic
- origin
- constrictions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the use of collagen of xenogeneic origin for inducing and/or increasing neovascularization and for the prophylaxis and/or treatment of diseases associated with vascular anomalies, especially in the form of constrictions and/or obstructions, whereby the collagen comprises an active ingredient complex.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005045671A DE102005045671A1 (en) | 2005-09-15 | 2005-09-15 | Use of a collagen of xenogenic origin |
DE102005045671.5 | 2005-09-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007031329A2 WO2007031329A2 (en) | 2007-03-22 |
WO2007031329A3 true WO2007031329A3 (en) | 2007-07-12 |
Family
ID=37564137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/009004 WO2007031329A2 (en) | 2005-09-15 | 2006-09-15 | Use of a collagen of xenogeneic origin |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102005045671A1 (en) |
WO (1) | WO2007031329A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001093880A1 (en) * | 2000-06-05 | 2001-12-13 | Yale University | Production and use of microvessels in a fibronectin-containing gel |
WO2002022157A2 (en) * | 2000-09-14 | 2002-03-21 | Transkaryotic Therapies, Inc. | Injectable hybrid matrix mixtures |
US20050064521A1 (en) * | 2003-09-24 | 2005-03-24 | Tunghai University | In vitro assay for evaluation of angiogenic effects |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4808402A (en) * | 1987-05-29 | 1989-02-28 | Northwestern University | Method and compositions for modulating neovascularization |
US4950483A (en) * | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US6419920B1 (en) * | 1995-10-25 | 2002-07-16 | Trans Karyotic Therapies, Inc. | Hybrid matrix implants and explants |
US5962025A (en) * | 1996-07-16 | 1999-10-05 | The University Of Tennessee Research Corporation | Method for treatment of systemic sclerosis and related fibrotic diseases |
WO1998035653A1 (en) * | 1997-02-13 | 1998-08-20 | Benedict, James, A. | Implantable collagen-containing putty material |
US6328765B1 (en) * | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
GB2344519B (en) * | 1998-12-07 | 2004-05-19 | Johnson & Johnson Medical Ltd | Sterile therapeutic compositions |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
AU4476600A (en) * | 1999-04-22 | 2000-11-10 | Vanderbilt University | Polymeric encapsulation system promoting angiogenesis |
US6506398B1 (en) * | 2000-04-28 | 2003-01-14 | Hosheng Tu | Device for treating diabetes and methods thereof |
WO2003017826A2 (en) * | 2001-08-27 | 2003-03-06 | Regeneration Technologies, Inc. | Processed soft tissue for topical or internal application |
TWI245634B (en) * | 2001-12-28 | 2005-12-21 | Ind Tech Res Inst | Preparation of a biodegradable thermal-sensitive gel system |
US8383158B2 (en) * | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
-
2005
- 2005-09-15 DE DE102005045671A patent/DE102005045671A1/en not_active Withdrawn
-
2006
- 2006-09-15 WO PCT/EP2006/009004 patent/WO2007031329A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001093880A1 (en) * | 2000-06-05 | 2001-12-13 | Yale University | Production and use of microvessels in a fibronectin-containing gel |
WO2002022157A2 (en) * | 2000-09-14 | 2002-03-21 | Transkaryotic Therapies, Inc. | Injectable hybrid matrix mixtures |
US20050064521A1 (en) * | 2003-09-24 | 2005-03-24 | Tunghai University | In vitro assay for evaluation of angiogenic effects |
Also Published As
Publication number | Publication date |
---|---|
DE102005045671A1 (en) | 2007-03-29 |
WO2007031329A2 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008115469A3 (en) | Role of hedgehog signaling in atherosclerosis and cardiovascular disease | |
WO2007037849A3 (en) | Compositions and methods for the intraocular transport of therapeutic agents | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
WO2006091459A3 (en) | Compositions and methods for treating vascular permeability | |
MX2007010560A (en) | Roflumilast for the treatment of diabetes mellitus. | |
TW200637522A (en) | Skin treatment articles and methods | |
WO2007027761A3 (en) | Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease | |
WO2006013441A3 (en) | Use of probiotic bacteria for the preparation of topical compositions for skin protection | |
WO2009091994A3 (en) | Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof | |
WO2008029276A3 (en) | Compositions and methods for the treatment of ophthalmic disease | |
WO2011065982A3 (en) | Polymorphisms associated with parkinson's disease | |
ATE456369T1 (en) | FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES | |
WO2010141648A3 (en) | Artificial tears and therapeutic uses | |
WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
MY172372A (en) | Compositions and methods for lowering triglycerides | |
MX2011009539A (en) | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof. | |
WO2005077093A3 (en) | Manufacture of highly phosphorylated lysosomal enzymes and uses thereof | |
WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
WO2006095029A3 (en) | Di-polymer protein conjugates and processes for their preparation | |
WO2012012718A3 (en) | Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof | |
WO2008060362A3 (en) | Methods and compositions for the treatment of skin diseases and disorders | |
DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
WO2006138048A3 (en) | Formulations comprising fluphenazine or derivatives thereof | |
WO2007051785A3 (en) | Use of sdf-1 for the treatment and/or prevention of neurological diseases | |
WO2006050826A3 (en) | Treatment of mastitis with enrofloxacin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06792086 Country of ref document: EP Kind code of ref document: A2 |